Statement of Robert K. Coughlin, President & CEO of MassBio, on Legislation to Repeal Medical Device Tax

Jan 11, 2018

“The growing convergence of medical device and biopharma companies is changing the lives of sick people around the world through the development of new combination products, and powerful diagnostics that allow for personalized medicines. Much of that work is being done in Massachusetts, home to more than 480 medical device companies which account for 14% of the state’s exports. We thank Senator Markey for reintroducing legislation to repeal the medical device tax, which unfairly penalizes medical device innovation and has the potential to stifle growth and patient access, especially among small manufactures and startups. Repeal of the medical device tax will allow this innovation to thrive and will ensure Massachusetts remains the best life sciences cluster in the world.”

         – Robert K. Coughlin, President and CEO of MassBio

See all MassBio News